ArticleCommunications medicine2025

Angiotensin receptor-neprilysin inhibitor treatment in people with chronic obstructive pulmonary disease and heart failure.

Wan-Hsuan Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.